OMass Therapeutics
Omass
Oxford, United Kingdom · $118.0M raised
- Total Funding
- $118.0M
- Last Round
- $100.0M Series BApr 2022
- Rounds
- 2
About
Biotech company harnessing native mass spectrometry and chemistry to discover small molecule drugs targeting membrane proteins and intracellular complexes.
Summary
OMass Therapeutics is a Biotech company based in Oxford, United Kingdom. It has raised $118.0M in total across 2 rounds, most recently a $100.0M Series B round in Apr 2022.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.